ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting ...
RxSight (NASDAQ:RXST) reported preliminary second-quarter financial results and provided updates on its product pipeline ...
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies; Collaboration aims to combine best-in-class ...
Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according ...
Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...
Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for cataract patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results